Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 10:11 PM
Study NCT ID:
NCT04643158
Status:
TERMINATED
Last Update Posted:
2025-08-28
First Post:
2020-11-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-20
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-23
First Submit QC Date:
None
Study First Post Date:
2020-11-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-02
Results First Submit QC Date:
None
Results First Post Date:
2025-08-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-27
Last Update Post Date:
2025-08-28
Last Update Post Date Type:
ESTIMATED